$267 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 41 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 176.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BBRE | Buy | JPM BETABLDRS MSCI US REITetfs | $212,248,000 | +11.1% | 2,708,621 | +24.5% | 79.54% | -3.8% |
EOCWU | ELLIOTT OPPORTUNITY II CORP | $19,750,000 | +0.8% | 2,000,000 | 0.0% | 7.40% | -12.7% | |
KRTX | New | KARUNA THERAPEUTICS INC | $11,199,000 | – | 49,788 | +100.0% | 4.20% | – |
IMTX | IMMATICS NV | $6,974,000 | +14.8% | 697,431 | 0.0% | 2.61% | -0.5% | |
TXN | TEXAS INSTRUMENTS INC | $4,953,000 | +0.7% | 32,000 | 0.0% | 1.86% | -12.7% | |
New | HASHICORP INC | $2,756,000 | – | 85,603 | +100.0% | 1.03% | – | |
VIR | New | VIR BIOTECHNOLOGY INC | $2,514,000 | – | 130,409 | +100.0% | 0.94% | – |
VT | VANGUARD TOT WORLD STK ETFetfs | $2,334,000 | -7.6% | 29,585 | 0.0% | 0.88% | -19.9% | |
BOND | PIMCO ACTIVE BOND EXCHANGE-T | $1,391,000 | -5.8% | 15,502 | 0.0% | 0.52% | -18.5% | |
XOM | New | EXXON MOBIL CORP | $960,000 | – | 10,993 | +100.0% | 0.36% | – |
CDAK | CODIAK BIOSCIENCES INC | $662,000 | -72.9% | 847,108 | 0.0% | 0.25% | -76.5% | |
GOOG | Buy | ALPHABET INC | $514,000 | +5611.1% | 5,350 | +133650.0% | 0.19% | +4725.0% |
APEN | Buy | APOLLO ENDOSURGERY INC | $172,000 | +201.8% | 31,202 | +100.0% | 0.06% | +156.0% |
AGLE | AEGLEA BIOTHERAPEUTICS INC | $129,000 | +4.0% | 245,678 | 0.0% | 0.05% | -11.1% | |
TFFP | TFF PHARMACEUTICALS INC | $90,000 | -28.0% | 22,066 | 0.0% | 0.03% | -37.0% | |
LXRX | LEXICON PHARMACEUTICALS INC | $86,000 | +30.3% | 35,714 | 0.0% | 0.03% | +10.3% | |
PLXP | Buy | PLX PHARMA INC | $81,000 | -46.7% | 125,346 | +100.0% | 0.03% | -54.5% |
POR | PORTLAND GENERAL ELECTRIC CO | $5,000 | -16.7% | 118 | 0.0% | 0.00% | -33.3% | |
TAK | New | TAKEDA PHARMACEUTIC | $2,000 | – | 137 | +100.0% | 0.00% | – |
UL | New | UNILEVER N.V. | $1,000 | – | 16 | +100.0% | 0.00% | – |
WPP | New | WPP PLC NEW/ADRnot used | $1,000 | – | 15 | +100.0% | 0.00% | – |
UBS | New | UBS GROUP AG | $1,000 | – | 67 | +100.0% | 0.00% | – |
TTE | New | TOTAL SA-SPON ADR | $1,000 | – | 14 | +100.0% | 0.00% | – |
AEG | New | AEGON N.V.-AMERICAN REG ADR | $1,000 | – | 136 | +100.0% | 0.00% | – |
BABA | New | ALIBABA GROUP HOLDING LTD | $1,000 | – | 8 | +100.0% | 0.00% | – |
ABEV | New | AMBEV SA | $1,000 | – | 231 | +100.0% | 0.00% | – |
BUD | New | ANHEUSER-BUSCH INBEV SA/NV | $1,000 | – | 13 | +100.0% | 0.00% | – |
KOF | New | COCA-COLA FEMSA SAB-SP ADR | $1,000 | – | 14 | +100.0% | 0.00% | – |
CS | New | CREDIT SUISSE GP SP ADR | $1,000 | – | 168 | +100.0% | 0.00% | – |
E | New | ENI S P A | $1,000 | – | 25 | +100.0% | 0.00% | – |
ERJ | New | EMBRAER SA | $1,000 | – | 90 | +100.0% | 0.00% | – |
ENIC | New | ENEL CHILE SA-ADR | $1,000 | – | 423 | +100.0% | 0.00% | – |
New | GSK PLC-SPON ADR | $1,000 | – | 29 | +100.0% | 0.00% | – | |
GRFS | New | GRIFOLS SA-ADR | $1,000 | – | 107 | +100.0% | 0.00% | – |
HMC | New | HONDA MOTOR CO LTD (ADR) | $1,000 | – | 25 | +100.0% | 0.00% | – |
MUFG | New | MITSUBISHI UFJ FINL GRP INC | $1,000 | – | 167 | +100.0% | 0.00% | – |
NVS | New | NOVARTIS AG | $1,000 | – | 14 | +100.0% | 0.00% | – |
ORAN | New | ORANGE SPON ADR | $1,000 | – | 91 | +100.0% | 0.00% | – |
PBRA | New | PETROLEO BRASIL SP PREF ADRnot used | $1,000 | – | 83 | +100.0% | 0.00% | – |
SNY | New | SANOFI-AVENTIS | $1,000 | – | 23 | +100.0% | 0.00% | – |
SAP | New | SAP SE SHS | $1,000 | – | 7 | +100.0% | 0.00% | – |
PEP | Exit | PEPSICO INC | $0 | – | -6 | -100.0% | 0.00% | – |
MSFT | Exit | MICROSOFT CORP | $0 | – | -44 | -100.0% | -0.01% | – |
WTTR | Exit | SELECT ENERGY SERVICES INC | $0 | – | -368,829 | -100.0% | -1.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4/A | 2024-05-14 |
4 | 2024-05-01 |
3 | 2024-04-30 |
13F-HR | 2024-04-30 |
144 | 2024-04-29 |
SC 13G | 2024-03-05 |
13F-HR | 2024-02-28 |
SC 13G | 2024-02-14 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-04 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.